CClinicalTrials.gg
RecruitingNCT07544238PROMISERUpdated Apr 27, 2026

Prospective Study of Minimally Invasive (Laparoscopic and Robotic) Hernia Repair (Incisional and Primary, Midline and Lateral, Not Inguinal)

An observational study in Ventral Hernia Midline, Hernia Lumbar and Incisional Hernia Repair, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

The participating researchers register all adult patients (who have given informed written consent) scheduled for elective repair of an abdominal wall hernia (NOT inguinal hernias) via minimally invasive operation technique (i.e.: laparoscopy or robotic repair) and perform a follow up of 5 years to analyze clinical outcome parameters. These parameters include recurrence of the hernia, intra- and postoperative complications, quality of live, esthetic outcome and pain.

The patients will be reviewed in person by the participating researchers at 2-3 moths, 1 year, 3 years and 5 years after surgery. A computed tomography will be performed at 1 year after surgery and in case of suspicion of complications, for example hernia recurrence. The treatment and follow-up of the participating patients does not differ from the standard treatment protocol (and the not participating patients).

02

Conditions studied

  • Ventral Hernia Midline
  • Hernia Lumbar
  • Incisional Hernia Repair
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All adults referred to our department presenting an abdominal wall hernia with surgical indication

Inclusion criteria

  • Indication for elective minimally invasive ventral hernia repair due to criteria of the participating surgeons

Exclusion criteria

Exclusion Criteria:

  • Patient rejects participation or giving written informed consent
  • Positive pregnancy test (Beta HCG in serum)
  • Patients who do not meet criteria for minimally invasive surgery due to the criteria of the including surgeon or anesthesiologist (Loss of domain, giant abdominal wall herniae, very small (W1) isolated midline hernia, severe pulmonary or cardiac pathologies)
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • All adult patients with indication of elective minimally invasive abdominal wall hernia surgery

    The patients will be intervened by laparoscopic or robotically assisted hernioplastia of midline or lumbar hernias, either primary or secondary in nature. Inguinal hernias will only be included if they exist apart from the primarily targeted midline or lumbar abdominal wall hernia

    Procedure: Minimally invasive hernioplastia

Interventions

  • ProcedureMinimally invasive hernioplastia

    laparoscopic or robotically assisted hernioplastia

05

What researchers measure

Primary outcomes

  1. Hernia recurrence rate

    Percentage of all the patients intervened who present a radiologically (via CAT Scan or MRI in case of contraindication for CAT Scan) confirmed hernia recurrence. In case of suspicion (physical exam and/or symptoms reported by the patient) a CAT Scan will be performed to confirm or discard the diagnosis, at any time of the follow-up

    Time frame: 5 years (the time to recurrence will be defined by the moment of radiological confirmation)

Secondary outcomes

  1. Postoperative complications Clavien Dindo

    Registration of postoperative complications according to the Clavien Dindo Definition

    Time frame: 90 days after surgery

  2. Surgical Site Occurrence (SSO)

    Any alteration of postoperative wound healing (including surgical site infection, hematoma, seroma and wound dehiscence) and the required intervention (none, bedside intervention, radiologically guided intervention, surgery)

    Time frame: 5 years

  3. Perioperative bleeding

    Any drop in serum hemoglobin levels \> 2 g/dl within 24 hours or \> 3 g/dl compared to preoperative values or hemodynamically relevant bleeding or necessity for blood transfusion or surgical reintervention because of bleeding

    Time frame: 30 days

  4. Mortality

    Percentage of the total of registered patients who perish

    Time frame: 5 years

  5. Hernia associated quality of life

    Hernia associated quality of life assessed by the EuraHS QoL (European Registry for Abdominal Wall Hernias Quality of Life Questionnaire). The questionnaire contemplates 9 items, scoring them with values of 0-10. They are subgroups into 3 items assessing pain, 4 items assessing restriction of activities and 2 items assessing the cosmetic outcome as perceived by the patient. A higher score means is linked to a worse outcome. 0 points would be the best outcome, 90 points the worst outcome possible.

    Time frame: 5 years

  6. Postoperative pain

    Postoperative pain measured via VAS (Visual Analogue Scale, valued with 0-10 points, lower numbers relating to less pain, higher numbers to more pain, that is: a worse outcome)

    Time frame: 24 and 48 hours after surgery (during the rest of the follow-up this value is included in the EuraHS QoL questionnaire)

  7. Reintervention Rate

    Percentage of the total of registered patients with surgical reintervention due to complications of the performed surgery (hernia recurrence or others)

    Time frame: 5 years

  8. Risk Factors

    Descrition of the incidence of known risk factors for hernia formation at the time of surgery (Diabetes mellitus, arterial hypertension, dislipemia, anti aggregation, anticoagulation, pathologies of the connective tissues like Ehlers-Danlos or Marfan syndrome, abdominal aortic ectasia or aneurysm, cardiac pathologies, active malignant disease, chemotherapy within the last 3 months, active smoking, alcohol abuse, chronic liver disease

    Time frame: Only at time of inclusion

  9. Prehabilitation

    Description of the percentage of patients treated with either Botox injection into the abdominal wall within 8 weeks before surgery and / or pulmonary prehabilitation and / or included in a weight loss program before surgery and / or have canceled an existing smoking habit before surgery

    Time frame: at the time of registration

06

Study locations

1 of 1 sites recruiting
  • Hospital Universitario Fundacion Jiménez Díaz
    Madrid, Madrid 28040, Spain
    Recruiting
07

References and documents

Study documents

  • Study protocol · Mar 9, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — All the raw data registered and relevant for the described primary and secondary outcomes, but NOT the personal details necessary to identify the person (birth date, name, medical record number). In essence: only the pseudonymized data is provided.

Supporting information: Study protocol, Sap, Icf

08

Registry details

Key details

Study ID
NCT07544238
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Responsible party
Marius Kaeser (Surgical Staff, Surgeon in the department of General Surgery of the Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) — Principal investigator
First posted
Apr 22, 2026
Start date
Apr 14, 2026
Primary completion
Apr 14, 2036 (estimated)
Completion
Apr 14, 2036 (estimated)
Last update
Apr 27, 2026

Study contacts

Marius Kaeser, Doctors Degree
Contact
marius.kaser@quironsalud.es
0034 915 50 48 00 ext. 4331

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion